Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	17	6	27	126	171	31
Market Cap Growth	111.47%	-77.28%	-78.89%	-26.16%	442.33%	234.37%
Enterprise Value	14	-1	25	101	136	20
PE Ratio	-	-0.35	-0.24	-2.16	-12.54	-1.16
PS Ratio	0.18	0.06	0.28	1.92	6.18	4.30
PB Ratio	0.55	0.15	0.60	0.92	1.80	4.44
P/FCF Ratio	1.95	-1.18	-0.92	-4.86	-6.02	-2.27
P/OCF Ratio	1.95	-1.18	-0.92	-4.86	-6.02	-2.28
EV/Sales Ratio	0.15	-0.01	0.26	1.54	4.91	2.76
EV/EBITDA Ratio	-3.33	0.07	-0.26	-2.07	-17.15	-0.83
EV/EBIT Ratio	-1.10	0.03	-0.23	-1.74	-9.96	-0.74
EV/FCF Ratio	1.60	0.11	-0.88	-3.89	-4.78	-1.45
Debt / Equity Ratio	0.54	0.42	0.41	0.18	0.14	-
Debt / EBITDA Ratio	-4.01	-1.99	-0.18	-0.51	-1.67	-
Debt / FCF Ratio	1.91	-3.19	-0.63	-0.95	-0.46	-
Quick Ratio	0.59	0.75	0.64	0.71	1.88	2.43
Current Ratio	0.85	1.06	0.93	0.96	2.62	2.87
Asset Turnover	0.71	0.75	0.51	0.31	0.27	0.22
Return on Equity (ROE)	-40.50%	-39.10%	-134.90%	-48.10%	-27.30%	-204.20%
Return on Assets (ROA)	-10.30%	-11.90%	-57.40%	-27.60%	-13.00%	-81.30%
Return on Capital (ROIC)	-4.00%	-32.37%	-178.51%	-36.26%	-19.53%	-237.68%
Earnings Yield	-80.11%	-281.91%	-408.69%	-46.22%	-7.98%	-86.17%
FCF Yield	51.31%	-84.80%	-108.29%	-20.59%	-16.62%	-44.12%
Buyback Yield / Dilution	-48.48%	-127.22%	-75.54%	-270.57%	-479.80%	-1071.03%
Total Shareholder Return	-48.48%	-127.22%	-75.54%	-270.57%	-479.80%	-1071.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).